Not classified as an open-market trade.
Loading…
Reporting person on SEC Form 4
Mary K Moreland
Mary K Moreland is EXECUTIVE VICE PRESIDENT at Abbott Laboratories. OQRO lists 5 transactions filed with the SEC under this name, the latest on Apr 29, 2026, each linked to the official Form 4.
EXECUTIVE VICE PRESIDENT
Disclosures on record
5
Companies involved
1
Disclosure history
Officer sold
~$71KReported value · 613 sh @ $115.58
Abbott Laboratories's EXECUTIVE VICE PRESIDENT sold $71K of Abbott Laboratories shares. Nobody planned it ahead of time.
Routine share withholding; mechanical by default.
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.